Concentra appoints two tech-savvy health care leaders to board

ADDISON, Texas - Concentra Group Holdings Parent, Inc. (NYSE:CON) has appointed Vipin Gopal and Brigid Bonner to its board of directors, expanding the board to seven members, according to a company press release. The healthcare services provider, currently valued at $2.63 billion, trades near its InvestingPro Fair Value with a solid financial health rating of GOOD.

Gopal brings over 25 years of experience in data, AI, and digital transformation at Fortune 100 companies. He previously served as Chief Data and Analytics Officer at Eli Lilly and Company and Walgreens Boots Alliance, and held senior leadership positions at Humana, Cigna, United Technologies Corporation, and Honeywell. Gopal holds a doctorate from Carnegie Mellon University, a B.Tech from the Indian Institute of Technology, and an MBA from NYU Stern School of Business.

Bonner is the president of Bonner Consulting, specializing in strategy and digital transformation. With more than 35 years of executive experience across nonprofit, for-profit, startup, and Fortune 100 organizations, she has worked in retail, technology, e-commerce, and health care sectors. Her previous roles include senior leadership positions at CaringBridge, UnitedHealth Group, IBM, Target Corporation, The Schwan Food Company, and SimonDelivers.com. Bonner earned her Bachelor of Science from Iowa State University and MBA from Harvard Business School.

"As Concentra navigates growth and the opportunity to increase shareholder value, expanding the board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company," said Bob Ortenzio, Concentra’s board chair.

Concentra, founded in 1979, is the largest provider of occupational health services in the United States by number of locations. The company operates 627 occupational health centers and 160 onsite health clinics across 45 states, serving approximately 50,000 patients daily as of March 31, 2025. For detailed analysis and additional insights, including multiple ProTips and comprehensive financial metrics, visit InvestingPro, where you’ll find the complete Pro Research Report for Concentra among 1,400+ top US stocks.

In other recent news, Concentra Group Holdings Parent Inc. reported a 7.1% increase in revenue for the first quarter of 2025, totaling $500.8 million. The company’s adjusted EBITDA also rose by 6.8%, although there was a slight dip in the EBITDA margin. Concentra has raised its revenue guidance for 2025, projecting a range of $2.1 billion to $2.15 billion, and expects adjusted EBITDA to be between $415 million and $430 million. The firm is set to finalize the acquisition of Pivot On-site in the second quarter of 2025, which will enhance its service offerings. Concentra has been active in expanding its health centers through strategic acquisitions, including the recent Nova Medical Centers acquisition. Despite these positive developments, the company’s stock fell by 1.42% following the earnings release, potentially due to broader market conditions. Analysts from firms such as JPMorgan and RBC Capital Markets have been monitoring Concentra’s performance, noting the company’s efforts in managing potential economic challenges.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.